# Octapharma Plasma, Inc. – FDA Inspection, Apr 24, 2019

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/d47fd450-a1a8-4e3b-b651-8abab62724d6
Source feed: FDA_Inspections

> FDA inspection 1089657 of Octapharma Plasma, Inc., April 24, 2019. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1089657
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2019-04-24
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 976436 - 2016-06-30
- FDA Inspection 806330 - 2012-10-25
- FDA Inspection 614657 - 2009-09-24

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/laura-e-garcia/ad7c9bee-bbff-494f-b9cf-35c3a04316c0)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/01c56ab1-5b65-4777-ae72-321592e2ba85

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d